Compounds > kt 5823
Page last updated: 2024-09-02

kt 5823 and charybdotoxin

kt 5823 has been researched along with charybdotoxin in 3 studies

Compound Research Comparison

Studies
(kt 5823)		Trials
(kt 5823)		Recent Studies (post-2010)
(kt 5823)		Studies
(charybdotoxin)		Trials
(charybdotoxin)		Recent Studies (post-2010) (charybdotoxin)
3170591,150088

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, S; Cornfield, DN; Reeve, HL; Tolarova, S; Weir, EK1
Flores-Murrieta, FJ; Granados-Soto, V; Mixcoatl-Zecuatl, T1
Granados-Soto, V; Medina-Tato, DA; Ortiz, MI; Palma-Martínez, J; Sarmiento-Heredia, D1

Other Studies

3 other study(ies) available for kt 5823 and charybdotoxin

ArticleYear
Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Jul-23, Volume: 93, Issue:15

    Topics: Alkaloids; Aminoquinolines; Animals; Carbazoles; Charybdotoxin; Endothelium, Vascular; Enzyme Inhibitors; Female; Fetus; Glyburide; Guanylate Cyclase; Hypoxia; Indoles; Isoquinolines; Membrane Potentials; Models, Cardiovascular; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Oxygen; Patch-Clamp Techniques; Peptides; Potassium Channel Blockers; Potassium Channels; Pregnancy; Protein Kinase Inhibitors; Pulmonary Artery; Sheep; Sulfonamides; Tetraethylammonium; Tetraethylammonium Compounds; Vasodilation

1996
The nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway participates in the antiallodynic effect of spinal gabapentin.
    European journal of pharmacology, 2006, Feb-15, Volume: 531, Issue:1-3

    Topics: Amines; Analgesics; Animals; Apamin; Carbazoles; Charybdotoxin; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclohexanecarboxylic Acids; Diazoxide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gabapentin; gamma-Aminobutyric Acid; Glyburide; Indazoles; Indoles; Injections, Spinal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Okadaic Acid; Oxadiazoles; Pain; Pinacidil; Potassium Channel Blockers; Potassium Channels; Protein Kinase Inhibitors; Quinoxalines; Rats; Rats, Wistar; Signal Transduction; Spinal Nerves; Stereoisomerism; Time Factors; Vasodilator Agents

2006
Possible activation of the NO-cyclic GMP-protein kinase G-K+ channels pathway by gabapentin on the formalin test.
    Pharmacology, biochemistry, and behavior, 2006, Volume: 83, Issue:3

    Topics: 4-Aminopyridine; Amines; Analgesics; Animals; Apamin; Carbazoles; Charybdotoxin; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Glyburide; Indoles; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pain Measurement; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Tolbutamide

2006